Furthermore, miR- 152 and -20b (by impairing the MAPK/ERK signaling pathway) were found to be related to more aggressive types of papillary thyroid cancer, advanced TNM stage, and lymph node metastasis (51, 96). Here, MAPK1 is linked to thyroid gland papillary carcinoma.